Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Ipsen Biopharmaceuticals, Inc. U.S. 401(K) Plan is a benefit plan reported by Ipsen Biopharmaceuticals, Inc under EIN 26-0042539 and plan number 001. The latest loaded filing year is 2023. The filing reports 1,063 participants and $165,883,134 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $165,883,134
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $165,883,134
- Net assets (BOY)
- $125,021,539
Income & contributions
- Employer contributions
- $14,494,898
- Participant contributions
- $13,875,402
- Total contributions
- $37,009,164
- Total income / additions
- $61,790,092
Expenses & distributions
- Benefits paid
- $20,818,373
- Administrative expenses
- $92,432
- Total expenses
- $20,928,497
- Net increase / (decrease)
- $40,861,595